HALOZYME THERAPEUTICS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of RV7 for the last quarter is 181.54 M EUR, and it's 12.90% lower compared to the previous quarter. The net income of Q1 24 is 71.20 M EUR.